Transaction in Own Shares

Summary by AI BETAClose X

Hikma Pharmaceuticals PLC has purchased 1,000,000 ordinary shares as part of its $250 million share repurchase program, with transactions occurring between July 20 and July 24, 2026, at prices ranging from 1,523.0000 pence to 1,595.0000 pence. The company intends to cancel these repurchased shares, and following these transactions, the total number of issued ordinary shares will be 210,729,832, with the total voting rights remaining the same.

Disclaimer*

UK 100